Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Transversus Abdominis Plane Block and Ilioinguinal / Iliohypogastric Nerve Block

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02991053
Recruitment Status : Unknown
Verified December 2016 by ILKE KUPELI, Erzincan University.
Recruitment status was:  Active, not recruiting
First Posted : December 13, 2016
Last Update Posted : December 13, 2016
Sponsor:
Information provided by (Responsible Party):
ILKE KUPELI, Erzincan University

Brief Summary:
the aim of this study is to compare the effects of Transversus abdominis plane block and ilioinguinal / iliohypogastric block combined with sedation in pediatric surgeon on the anesthesia and analgesia contributions during surgery without general anesthesia.

Condition or disease Intervention/treatment Phase
Intra-operative Anesthesia Drug: ketamine Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Official Title: Ultrasonography Guided Ilioinguinal /Iliohypogastric Block Versus Transversus Abdominis Plane Block in Intraoperative Anesthesia in Children - Randomized Controlled Study
Study Start Date : December 2016
Estimated Primary Completion Date : August 2017
Estimated Study Completion Date : November 2017

Resource links provided by the National Library of Medicine

Drug Information available for: Ketamine

Arm Intervention/treatment
Active Comparator: block and ketamine
Transversus Abdominis Plane block after ketamine atropine induction and continued with ketamine only in anesthesia
Drug: ketamine
Active Comparator: block; ketamine with laryngeal mask; inhalation anesthesia
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and applied Transversus Abdominis Plane block.
Drug: ketamine
Active Comparator: block and ketamine ıh/ıl
Ilioinguinal / iliohypogastric block after ketamine atropine induction and continued with ketamine only in anesthesia
Drug: ketamine
Active Comparator: ıh/ıl block; ketamine; inhalation anesthesia
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and applied Ilioinguinal / iliohypogastric block.
Drug: ketamine
Active Comparator: control group
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and Non-block, postoperative analgesia with paracetamol IV
Drug: ketamine



Primary Outcome Measures :
  1. Amount of anesthetic drug which was used [ Time Frame: 2 hour ]

Secondary Outcome Measures :
  1. Postoperative visual analogue scale [ Time Frame: one day ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Years to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • American society of anesthesia score I-II
  • To undergo elective lower abdominal surgery
  • between 2-6 years old

Exclusion Criteria:

  • Patients with psychiatric disease
  • Patients whose weight is more than 40 kg
  • Patients with cardiac-pulmonary-neurological disease
  • Patients with bleeding disorder
  • Patients with infection or scar on the injection area
  • Patients with known allergies to local anesthetics

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02991053


Sponsors and Collaborators
Erzincan University
Investigators
Layout table for investigator information
Principal Investigator: ilke kupeli Erzincan University

Publications:

Layout table for additonal information
Responsible Party: ILKE KUPELI, assist. prof., Erzincan University
ClinicalTrials.gov Identifier: NCT02991053     History of Changes
Other Study ID Numbers: ERZINCAN UNIVERSITY 8
First Posted: December 13, 2016    Key Record Dates
Last Update Posted: December 13, 2016
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by ILKE KUPELI, Erzincan University:
Intra-operative anesthesia
Pediatric patient
Transversus Abdominis Plane Block
ilioinguinal / iliohypogastric nerve block

Additional relevant MeSH terms:
Layout table for MeSH terms
Anesthetics
Ketamine
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action